Drug Manufacturing Innovation Act of 2022
Official title: To amend the Federal Food, Drug, and Cosmetic Act to authorize a program to support the adoption of, and improve the development of, innovative approaches to p… Show full official titleShow less
Official title: To amend the Federal Food, Drug, and Cosmetic Act to authorize a program to support the adoption of, and improve the development of, innovative approaches to pharmaceutical product design and manufacturing, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Drug Manufacturing Innovation Act of 2022
This bill requires the Food and Drug Administration to establish a program to support innovative approaches to pharmaceutical product design and manufacturing, including through grants, regulatory guidance, and working groups.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6988: Drug Manufacturing Innovation Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6988/
"H.R. 6988: Drug Manufacturing Innovation Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6988/.
H.R. 6988, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6988/.
[H.R. 6988: Drug Manufacturing Innovation Act of 2022](https://openamerica.io/bill/117-HR-6988/)